These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 21098225)

  • 1. A marked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells.
    Hunzeker JT; Elftman MD; Mellinger JC; Princiotta MF; Bonneau RH; Truckenmiller ME; Norbury CC
    J Immunol; 2011 Jan; 186(1):183-94. PubMed ID: 21098225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquisition of MHC:peptide complexes by dendritic cells contributes to the generation of antiviral CD8+ T cell immunity in vivo.
    Smyth LA; Hervouet C; Hayday T; Becker PD; Ellis R; Lechler RI; Lombardi G; Klavinskis LS
    J Immunol; 2012 Sep; 189(5):2274-82. PubMed ID: 22821960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.
    Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF
    J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
    Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
    J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.
    Duewell P; Kisser U; Heckelsmiller K; Hoves S; Stoitzner P; Koernig S; Morelli AB; Clausen BE; Dauer M; Eigler A; Anz D; Bourquin C; Maraskovsky E; Endres S; Schnurr M
    J Immunol; 2011 Jul; 187(1):55-63. PubMed ID: 21613613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph-borne CD8α+ dendritic cells are uniquely able to cross-prime CD8+ T cells with antigen acquired from intestinal epithelial cells.
    Cerovic V; Houston SA; Westlund J; Utriainen L; Davison ES; Scott CL; Bain CC; Joeris T; Agace WW; Kroczek RA; Mowat AM; Yrlid U; Milling SW
    Mucosal Immunol; 2015 Jan; 8(1):38-48. PubMed ID: 24850430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosterone impairs MHC class I antigen presentation by dendritic cells via reduction of peptide generation.
    Truckenmiller ME; Princiotta MF; Norbury CC; Bonneau RH
    J Neuroimmunol; 2005 Mar; 160(1-2):48-60. PubMed ID: 15710457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes.
    Kamphorst AO; Guermonprez P; Dudziak D; Nussenzweig MC
    J Immunol; 2010 Sep; 185(6):3426-35. PubMed ID: 20729332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of murine tumour growth through CD8
    Kogo H; Shimizu M; Negishi Y; Uchida E; Takahashi H
    Immunology; 2017 Jul; 151(3):324-339. PubMed ID: 28294313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
    Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
    J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential role of endogenous heat shock protein 90 of dendritic cells in antigen cross-presentation.
    Ichiyanagi T; Imai T; Kajiwara C; Mizukami S; Nakai A; Nakayama T; Udono H
    J Immunol; 2010 Sep; 185(5):2693-700. PubMed ID: 20668218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication.
    van Mierlo GJ; Boonman ZF; Dumortier HM; den Boer AT; Fransen MF; Nouta J; van der Voort EI; Offringa R; Toes RE; Melief CJ
    J Immunol; 2004 Dec; 173(11):6753-9. PubMed ID: 15557168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
    Krishnan L; Sad S; Patel GB; Sprott GD
    J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo.
    Stober D; Jomantaite I; Schirmbeck R; Reimann J
    J Immunol; 2003 Mar; 170(5):2540-8. PubMed ID: 12594280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8 alpha+ dendritic cells.
    Tagliani E; Guermonprez P; Sepúlveda J; López-Bravo M; Ardavín C; Amigorena S; Benvenuti F; Burrone OR
    J Immunol; 2008 Mar; 180(5):3201-9. PubMed ID: 18292544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
    Klotz L; Hucke S; Thimm D; Classen S; Gaarz A; Schultze J; Edenhofer F; Kurts C; Klockgether T; Limmer A; Knolle P; Burgdorf S
    J Immunol; 2009 Jul; 183(1):129-36. PubMed ID: 19535643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin CD11b negatively regulates TLR9-triggered dendritic cell cross-priming by upregulating microRNA-146a.
    Bai Y; Qian C; Qian L; Ma F; Hou J; Chen Y; Wang Q; Cao X
    J Immunol; 2012 Jun; 188(11):5293-302. PubMed ID: 22551553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple intracellular routes in the cross-presentation of a soluble protein by murine dendritic cells.
    Palliser D; Guillen E; Ju M; Eisen HN
    J Immunol; 2005 Feb; 174(4):1879-87. PubMed ID: 15699114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL.
    Luketic L; Delanghe J; Sobol PT; Yang P; Frotten E; Mossman KL; Gauldie J; Bramson J; Wan Y
    J Immunol; 2007 Oct; 179(8):5024-32. PubMed ID: 17911587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.